A census of human cancer genes PA Futreal, L Coin, M Marshall, T Down, T Hubbard, R Wooster, ... Nature reviews cancer 4 (3), 177-183, 2004 | 3943 | 2004 |
Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2857 | 2007 |
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1508 | 2017 |
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants 1958 Birth Cohort Controls: Jones Richard W 18 McArdle Wendy L 18 Ring Susan ... Nature genetics 39 (11), 1329-1337, 2007 | 1461 | 2007 |
Modeling linkage disequilibrium increases accuracy of polygenic risk scores BJ Vilhjálmsson, J Yang, HK Finucane, A Gusev, S Lindström, S Ripke, ... The american journal of human genetics 97 (4), 576-592, 2015 | 1454 | 2015 |
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. CBC Consortium. Nature Genetics 31 (1), 55-9, 2002 | 1434 | 2002 |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1314 | 2013 |
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ... Nature genetics 39 (2), 165-167, 2007 | 1234 | 2007 |
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, DF Easton, ... Journal of the National Cancer Institute 91 (11), 943-949, 1999 | 1143 | 1999 |
Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014 | 1142 | 2014 |
Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015 | 1068 | 2015 |
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls Nature 464 (7289), 713-720, 2010 | 949 | 2010 |
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial A Tutt, H Tovey, MCU Cheang, S Kernaghan, L Kilburn, P Gazinska, ... Nature medicine 24 (5), 628-637, 2018 | 914 | 2018 |
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles A Renwick, D Thompson, S Seal, P Kelly, T Chagtai, M Ahmed, B North, ... Nature genetics 38 (8), 873-875, 2006 | 889 | 2006 |
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles S Seal, D Thompson, A Renwick, A Elliott, P Kelly, R Barfoot, T Chagtai, ... Nature genetics 38 (11), 1239-1241, 2006 | 875 | 2006 |
Genome-wide association study identifies five new breast cancer susceptibility loci C Turnbull, S Ahmed, J Morrison, D Pernet, A Renwick, M Maranian, ... Nature genetics 42 (6), 504-507, 2010 | 845 | 2010 |
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer S Reid, D Schindler, H Hanenberg, K Barker, S Hanks, R Kalb, ... Nature genetics 39 (2), 162-164, 2007 | 749 | 2007 |
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B S Hanks, K Coleman, S Reid, A Plaja, H Firth, D FitzPatrick, A Kidd, ... Nature genetics 36 (11), 1159-1161, 2004 | 722 | 2004 |
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A S Nejentsev, JMM Howson, NM Walker, J Szeszko, SF Field, HE Stevens, ... Nature 450 (7171), 887-892, 2007 | 719 | 2007 |
Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... Journal of the National Cancer Institute 107 (5), djv036, 2015 | 711 | 2015 |